Bevonescein

N/A

Report date: 2024/09/14 20:00:06

Base Information

Drug NameBevonescein
Drug Alias NameALM-488
ClassificationSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC)Diagnostic agent (In vivo)
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHead and Neck NeoplasmsThyroid Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesAlume Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlume Biosciences Inc
Inactive CompaniesN/A
Active IndicationsHead and Neck NeoplasmsThyroid Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A